With TB being such a multi-faceted disease, what aspect does your research focus on?
My work focuses on how we can use a two-headed targeted degrader molecule to redirect Mtb’s own proteolytic systems to degrade the very essential proteins the bacteria need to survive.
What’s your favorite part of studying TB?
My favorite part of studying TB is the hope that our work can form a small part of a global collaborative effort to address the devastating impact that this infection has on public health worldwide. It remains a big problem, and it’s a privilege to be able to be involved in this work.
